U.S., Feb. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07390240) titled 'The Effect of Monoallelic Variants in the ALPL Gene on the Natural Course of Hypophosphatasia in Russia' on Dec. 15, 2025.
Brief Summary: The effect of monoallelic variants in the ALPL gene on the natural course of hypophosphatasia (HPP) in children and adults in Russia (ATLANTIS)
Study Start Date: Dec. 29, 2025
Study Type: OBSERVATIONAL
Condition:
Hypophosphatasia
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Published by HT Digital Content Services with permission from Health Daily Digest....